Table 2. Comparison of Imaging Modalities for Multiple Myeloma.
Strong Point | Weak Point | |
---|---|---|
CSS | • Low cost • Easy accessibility |
• Low sensitivity to detection of bone lesions • A significant amount of bone must be lost to be seen on X-rays • Long acquisition time • Limited bone marrow evaluation • Difficulty in distinguishing between benign and malignant compression fractures • Difficulty evaluating treatment responses |
LDWBCT | • Higher sensitivity than CSS to osteolytic lesions • A biopsy, surgery or radiation treatment plan may be available • Possible to detect extramedullary lesions • Cheaper than PET/CT or WBMR |
• Radiation exposure • Difficulty evaluating treatment responses • Higher cost than CSS • Unable to identify lesions prior to bone destruction or diffuse lesions in the bone marrow |
Whole body MRI | • No radiation exposure • Both diffuse or focal bone marrow lesions can be detected • High sensitivity to detect bone marrow lesions • Good for detecting extramedullary lesions or compression fractures • Can be used for prognostic evaluation • A biopsy, surgery or radiation treatment plan may be available |
• Higher cost compared to CSS and LDWBCT • Long acquisition time |
PET/CT | • Possible to evaluate the activity of the disease before and after treatment • Ability to evaluate extramedullary lesions • CT component can define lytic diseases |
• Higher cost compared to CSS and LDWBCT • Long acquisition time • Radiation exposure • High false positive rate • Poor resolution |
Adapted from Lee et al. Korean J Radiol 2021;22:1497-1513 (7).
CSS = conventional skeletal survey, LDWBCT = low dose whole body CT